https://mararating.com/report/cipaglucosidase-for-treating-late-onset-pompe-disease-as-of-august-2023-market-access-risk-assessment/
Cipaglucosidase alfa / pombiliti for treating late-onset Pompe disease as of August 2023 | MARA...
Sep 28, 2026 - As of August 2023, MARA's assessment finds Cipaglucosidase alfa / Pombiliti's reimbursement risk concentrated in comparator selection.
cipaglucosidase alfapompe diseasepombilititreatinglate
https://najdi-lekarnu.cz/lek/0271591
Pombiliti, 105mg inf plv csl 1
Lék Pombiliti, 105mg inf plv csl 1
pombilitiinfplvcsl